Greg Tourangeau - 10 May 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Principal Accounting Officer
Signature
/s/ Gregory Tourangeau
Issuer symbol
FULC
Transactions as of
10 May 2023
Net transactions value
-$695
Form type
4
Filing time
11 May 2023, 16:12:00 UTC
Previous filing
13 Feb 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FULC Common Stock Sale $695 -210 -1.3% $3.31 15,992 10 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.